GSK would continue to make Advair inhalers in Zebulon if generic competition emerges this year. It also makes new asthma inhalers and two HIV drugs at its Zebulon facility.
GSK would continue to make Advair inhalers in Zebulon if generic competition emerges this year. It also makes new asthma inhalers and two HIV drugs at its Zebulon facility. Chris Seward cseward@newsobserver.com
GSK would continue to make Advair inhalers in Zebulon if generic competition emerges this year. It also makes new asthma inhalers and two HIV drugs at its Zebulon facility. Chris Seward cseward@newsobserver.com

GSK ready for Advair’s rivals

February 08, 2017 05:32 PM